Turner, Maria L.
National Institutes of Health · National Human Genome Research Institute · National Cancer Institute · Center for Cancer Research
5 papers on CoChat
Most cited papers
- Verified
Topographical and Temporal Diversity of the Human Skin Microbiome
Grice, E. A., Kong, H. H., Conlan, S., Deming, C. B., Davis, J., Young, A. C., Program, N. C. S., Bouffard, G. G., Blakesley, R. W., Murray, P. R., et al. (2009) · Science
Dermatology and Skin DiseasesMicrobial Community Ecology and Physiology
Cited by 2,953
- Verified
Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis
Kong, H. H., Oh, J., Deming, C., Conlan, S., Grice, E. A., Beatson, M. A., Nomicos, E., Polley, E. C., Komarow, H. D., Program, N. C. S., et al. (2012) · Genome Research
Dermatology and Skin DiseasesContact Dermatitis and Allergies
Cited by 1,808
- Verified
Defining early mycosis fungoides
Pimpinelli, N., Olsen, E. A., Santucci, M., Vonderheid, E., Haeffner, A. C., Stevens, S., Burg, G., Cerroni, L., Dreno, B., Glusac, E., et al. (2005) · Journal of the American Academy of Dermatology
Cutaneous lymphoproliferative disorders researchLymphoma Diagnosis and Treatment
Cited by 550
- Verified
Effects of Naloxone Infusions in Patients with the Pruritus of Cholestasis: A Double-Blind, Randomized, Controlled Trial
Bergasa, N. V., Alling, D. W., Talbot, T. L., Swain, M. G., Yurdaydin, C., Turner, M. L., Schmitt, J. M., Walker, E. C., & Jones, E. A. (1995) · Annals of Internal Medicine
Dermatology and Skin DiseasesLiver Diseases and Immunity
Cited by 365
- Verified
Open‐label trial of oral nalmefene therapy for the pruritus of cholestasis
Bergasa, N. V., Schmitt, J. M., Talbot, T. L., Alling, D. W., Swain, M. G., Turner, M. L., Jenkins, J. B., & Jones, A. E. (1998) · Hepatology
Dermatology and Skin DiseasesLiver Diseases and Immunity
Cited by 182
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free